Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use EXELON PATCH safely and effectively. See full prescribing information for EXELON PATCH. EXELON® PATCH (rivastigmine transdermal system)Initial U.S. Approval: 2000
Medication labelWhy this: Advisory · dailymed-prescription
EXELON PATCH is indicated for the treatment of dementia of the Alzheimer’s type (AD). Efficacy has been demonstrated in patients with mild, moderate, and severe Alzheimer’s disease. EXELON PATCH is indicated for the treatment of mild-to-moderate dementia associated with Parkinson’s disease (PDD).
- generic_name
- rivastigmine
- product_names
- rivastigmine
- ndc
- 0078-0501, 0078-0501-61, 0078-0501-15, 0078-0502, 0078-0502-61, 0078-0502-15, 0078-0503, 0078-0503-61, 0078-0503-15
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en